Changjian Lin - Publications

Cryoballoon ablation versus antiarrhythmic drug therapy as initial treatment for persistent atrial fibrillation: the multicenter randomized CEPAF trial.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: May 11, 2026

Catheter Ablation of Idiopathic Premature Ventricular Contractions Using Robotic Magnetic Navigation: Extensive Experience and Review.

Journal: Journal of cardiovascular electrophysiology

Published: April 25, 2026

Subclinical Atrial Fibrillation Prediction in Patients with CIED by a Novel Deep Learning Framework.

Journal: Journal of cardiovascular development and disease

Published: November 12, 2025

Pulsed Field Ablation Terminated Atrial Fibrillation Triggered by Persistent Left Superior Vena Cava: A Case Report.

Journal: Clinical case reports

Published: October 26, 2025

Improved procedural efficiency of atrial fibrillation ablation using robotic magnetic navigation.

Journal: Heart rhythm O2

Published: July 30, 2025

Exosomal Prolactin-Induced Protein Inhibits the Activation of cGMP/PKG Pathway Mediated by ATP2B2 to Promote Myocardial Fibrosis in Atrial Fibrillation.

Journal: Antioxidants & redox signaling

Published: March 17, 2025

Pacemaker implantation is associated with post-ablation atrial fibrillation recurrence mediated by plasma CILP1.

Journal: Scientific reports

Published: March 17, 2025

A pilot experience on 5G telerobotic long-distance magnetic navigation-guided ablation for cardiac arrhythmias.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: March 02, 2025

Long-term outcomes of cryoballoon versus robotic magnetic navigation guided radiofrequency ablation in patients with persistent atrial fibrillation.

Journal: Scientific reports

Published: September 27, 2024

Identification of senescence-related genes for potential therapeutic biomarkers of atrial fibrillation by bioinformatics, human histological validation, and molecular docking.

Journal: Heliyon

Published: April 20, 2024

Senescent CD8+ T cells: a novel risk factor in atrial fibrillation.

Journal: Cardiovascular research

Published: April 02, 2024

Soluble PILRα: A novel plasma biomarker for atrial fibrillation progression and recurrence after catheter ablation.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: October 14, 2023